Development and Characterization of Nanoparticles for the Delivery of Gemcitabine Hydrochloride

Figure 3

(a) Cumulative % drug release (in vitro) for F1–F4. (b) Cumulative % drug release (in vitro) for F5–F8.

(a)

(b)